MindSens provides a technology platform for the early detection of dementia by identifying Alzheimer's biomarkers up to 15 years before symptoms appear. The system offers constant monitoring of these biomarkers, alerts for early risk signs, and actionable lifestyle suggestions to promote brain health. It is designed for individuals and caregivers seeking proactive, data-driven dementia care.
Funding
Funding not disclosed
Founders
Product
Problem
Millions of people are at high risk of dementia, but it is often diagnosed too late for effective care. This delayed diagnosis prevents early intervention and limits the potential for lifestyle changes that could slow disease progression.
Solution
MindSens offers a comprehensive platform for the early detection and ongoing management of dementia risk. The technology identifies Alzheimer's biomarkers up to 15 years before symptoms appear, enabling proactive intervention. The system provides constant monitoring of these biomarkers to identify trends, flags significant changes that may indicate early risk signs, and delivers actionable lifestyle suggestions to promote brain health. This approach empowers users with the information needed to take control of their cognitive well-being.
Target Audience
Primary customers are individuals at high risk of dementia, as well as their caregivers and healthcare providers seeking proactive, data-driven tools for early detection and management.
Features
- Detects Alzheimer's biomarkers up to 15 years before symptom onset
- Provides constant monitoring of dementia biomarkers to identify trends
- Flags significant changes in biomarkers to alert for early risk signs
- Offers actionable lifestyle suggestions to promote brain health
- Utilizes a patentable method for early detection and monitoring